CVE-2026-28391
Openclaw command injection
- Published5 Mar 2026
Description
OpenClaw versions prior to 2026.2.2 fail to properly validate Windows cmd.exe metacharacters in allowlist-gated exec requests (non-default configuration), allowing attackers to bypass command approval restrictions. Remote attackers can craft command strings with shell metacharacters like & or %...% to execute unapproved commands beyond the allowlisted operations.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2026-28391 being actively exploited?
CVE-2026-28391 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.92%.
How severe is CVE-2026-28391?
CVE-2026-28391 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.92% probability of exploitation.
Which products are affected by CVE-2026-28391?
Affected products include Openclaw.
How do I fix CVE-2026-28391?
Upgrade affected software to a fixed version, for example Openclaw 2026.2.2 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2026-28391 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.